FXH – First Trust Health Care AlphaDEX® Fund
First Trust Health Care AlphaDEX® Fund (FXH) is a Health ETF, issued by First Trust, $1.1B in assets, 0.58% expense ratio.
Returns as of Oct 23, 2026: 1 week +2.1%, 1 year +19.5%.
Selects health care stocks from Russell 1000® Index using AlphaDEX® methodology to generate positive alpha relative to traditional passive indices.
Top holdings
- CNC – Centene Corp, 2.7%
- HALO – Halozyme Therapeutics Inc, 2.7%
- CI – Cigna Corp, 2.6%
- GMED – Globus Medical, 2.5%
- ZBH – Zimmer Biomet Holdings Inc, 2.4%
- UHS – Universal Health Services Inc, 2.4%
- CAI – Caris Life Sciences, Inc. Common Stock, 2.4%
- SOLV – Solventum Corp., 2.3%
- DXCM – DexCom Inc, 2.3%
- CORT – Corcept Therapeutics Incorporated, 2.2%
- NTRA – Natera Inc, 2.2%
- MEDP – Medpace Holdings Inc, 2.2%
- GH – Guardant Health Inc, 2.1%
- ZTS – Zoetis Inc, 2.1%
- EXEL – Exelixis Inc, 2.1%
- REGN – Regeneron Pharmaceuticals Inc, 2.0%
- LLY – Eli Lilly and Company, 2.0%
- THC – Tenet Healthcare Corporation, 2.0%
- COO – The Cooper Companies, Inc, 1.9%
- GEHC – GE HealthCare Technologies Inc., 1.9%
- AMGN – Amgen Inc, 1.9%
- TEM – Tempus AI, Inc. Class A Common Stock, 1.9%
- MDT – Medtronic PLC, 1.9%
- BSX – Boston Scientific Corp, 1.9%
- UTHR – United Therapeutics Corporation, 1.9%